NIMHANS launches a Neuropathy Lecture Series to improve diagnosis and management of neuropathy, supported by Jenburkt Pharmaceuticals.

An Indian pharmaceutical company is manufacturing unlicensed, highly addictive opioids and exporting them illegally to West ...

A recent study links long-term consumption of chlorinated water to higher risks of cancers, including bladder, colorectal, ...

Zealand’s CEO Adam Steensberg said that the company is “exactly where it wants to be” in terms of its partnering and ...

Shares of Telix Pharmaceuticals surged to a record high on Friday after the company forecast annual bumper revenue, while its full-year earnings for 2024 soared more than ninefold. The Australian ...

Dr. Mehmet Oz holds millions of dollars worth of shares in health insurance, fertility, pharmaceutical and vitamin companies ...

Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement ...

Bausch Health reported strong Q4 results with a 6.2% Y/Y revenue increase and positive net income, driving a 10% stock rally.

Eli Lilly’s (LLY) new weight loss pill is still in clinical trials and has not yet been approved by regulators. But that hasn ...

On Jan. 2, Poolbeg said that it was in talks with Hookipa over an all-share takeover. Under the deal discussed at the time, accepting Poolbeg shareholders would have gotten 0.03 Hookipa shares for ...

On Jan. 2, Hookipa inked a non-binding agreement that would have created a merged company with Poolbeg via an all-stock ...

In this edition of “Psychedelic”, The Fly conducted an exclusive interview with Joseph Tucker, Chief Executive Officer and Director of Enveric ...